Position in NVCR
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$28,815
+$5,904 QoQ
Shares Held
1,902
-9.5% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#12
of 29 holders
Holding Since
Mar 2022
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVCR Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026SJS Investment Consulting Inc. holds $1,013,517 across 71 Medical Devices names. NVCR ranks #8 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
3,030 | $274,941 | |
| 2 | SYK |
Stryker Corp
|
721 | $226,998 | |
| 3 | MDT |
Medtronic plc
|
1,285 | $100,525 | |
| 4 | DXCM |
Dexcom Inc
|
1,025 | $69,033 | |
| 5 | PODD |
Insulet Corp
|
435 | $66,228 | |
| 6 | STE |
STERIS plc
|
175 | $36,849 | |
| 7 | GMED |
Globus Medical Inc
|
388 | $30,655 | |
| 8 | NVCR |
NovoCure Ltd
This page
|
1,902 | $28,815 |
All Filings in NVCR
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $28,815 | 1,902 | Shares | Defined | 2026-07-22 | |
| 2026-03-31 | $22,911 | 2,102 | Shares | Defined | 2026-04-23 | |
| 2025-12-31 | $41,143 | 3,182 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $40,827 | 3,160 | Shares | Sole | 2025-10-21 | |
| 2023-12-31 | $179 | 12 | Shares | Sole | 2024-01-16 | |
| 2023-09-30 | $193 | 12 | Shares | Sole | 2023-10-17 | |
| 2023-06-30 | $498 | 12 | Shares | Sole | 2023-07-13 | |
| 2023-03-31 | $721 | 12 | Shares | Sole | 2023-04-20 | |
| 2022-12-31 | $880 | 12 | Shares | Sole | 2023-01-23 | |
| 2022-09-30 | $911 | 12 | Shares | Sole | 2022-10-13 | |
| 2022-03-31 | $994 | 12 | Shares | Sole | 2022-05-05 | |
| No filing history on record for this holder in this stock. | ||||||